303 related articles for article (PubMed ID: 33133013)
1. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis.
Zhang F; Zheng B; Yu X; Wang X; Wang S; Teng W
Front Endocrinol (Lausanne); 2021; 12():675643. PubMed ID: 34322091
[TBL] [Abstract][Full Text] [Related]
3. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
4. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
[TBL] [Abstract][Full Text] [Related]
5. Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules.
Chen ML; Xu D; Yan XQ; Xie BJ
Asian J Surg; 2023 Jan; 46(1):156-159. PubMed ID: 35277319
[TBL] [Abstract][Full Text] [Related]
6. Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.
Shuai Y; Yue K; Duan Y; Zhou M; Fang Y; Liu J; Liu D; Jing C; Wu Y; Wang X
Front Endocrinol (Lausanne); 2021; 12():620147. PubMed ID: 34211434
[TBL] [Abstract][Full Text] [Related]
7. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
10. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
12. Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.
Back K; Choe JH; Kim JS; Kim JH
Eur J Surg Oncol; 2021 Jun; 47(6):1339-1345. PubMed ID: 33744024
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
14. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
15. Influence of Tumor Number on Clinicopathologic Features and Outcomes of Patients With Papillary Thyroid Carcinoma.
Feng JW; Wu WX; Hu J; Hong LZ; Qin AC; Jiang Y; Ye J
Am J Clin Pathol; 2020 Nov; 154(6):848-858. PubMed ID: 32789442
[TBL] [Abstract][Full Text] [Related]
16. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
[TBL] [Abstract][Full Text] [Related]
17. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
18. An Ultrasound-based Prediction Model for Occult Contralateral Papillary Thyroid Carcinoma in Adolescents and Young Adults.
Wei Y; Sheng D; Chang C; Tong Y
Acad Radiol; 2023 Mar; 30(3):453-460. PubMed ID: 36075824
[TBL] [Abstract][Full Text] [Related]
19. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
20. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
